Clinical Trial

GenSci143 in Participants With Advanced Solid Tumors

Name: GenSci143 in Participants With Advanced Solid Tumors — clinical trial record (NCT07252414)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of GenSci143 in Participants with Advanced Solid Tumors

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-19.

Status change: Not Yet Recruiting → Recruiting 2025-12-30

Trial Details

NCT Number	NCT07252414
Lead Sponsor	Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	180 participants
Start Date	2025-12-20
Primary Completion	2028-10-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-05